WO2006058043A3 - Vaccins contraceptifs pour chiens et chats a base d'antigenes issus de membrane d'oeuf - Google Patents

Vaccins contraceptifs pour chiens et chats a base d'antigenes issus de membrane d'oeuf Download PDF

Info

Publication number
WO2006058043A3
WO2006058043A3 PCT/US2005/042399 US2005042399W WO2006058043A3 WO 2006058043 A3 WO2006058043 A3 WO 2006058043A3 US 2005042399 W US2005042399 W US 2005042399W WO 2006058043 A3 WO2006058043 A3 WO 2006058043A3
Authority
WO
WIPO (PCT)
Prior art keywords
dogs
membrane antigens
egg membrane
contraceptive vaccines
cats based
Prior art date
Application number
PCT/US2005/042399
Other languages
English (en)
Other versions
WO2006058043A2 (fr
Inventor
Olga Chertihin
Wei He
John C Herr
Original Assignee
Univ Virginia
Olga Chertihin
Wei He
John C Herr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia, Olga Chertihin, Wei He, John C Herr filed Critical Univ Virginia
Publication of WO2006058043A2 publication Critical patent/WO2006058043A2/fr
Publication of WO2006058043A3 publication Critical patent/WO2006058043A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette invention concerne de nouvelles séquences d'acides aminés et d'acides nucléiques ePLA2y, MOP et ePAD ainsi que leurs composés et leurs procédés d'utilisation dans la modulation de la fertilité, induisant une réponse immunitaire et empêchant la conception ou la rendant plus difficile. Un aspect selon l'invention concerne un vaccin contraceptif contenant au moins une nouvelle protéine d'oeuf, un homologue, un fragment ou dérivé de celle-ci.
PCT/US2005/042399 2004-11-23 2005-11-23 Vaccins contraceptifs pour chiens et chats a base d'antigenes issus de membrane d'oeuf WO2006058043A2 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US63050704P 2004-11-23 2004-11-23
US63031004P 2004-11-23 2004-11-23
US60/630,310 2004-11-23
US60/630,507 2004-11-23
US63588504P 2004-12-14 2004-12-14
US60/635,885 2004-12-14
US72587105P 2005-10-11 2005-10-11
US60/725,871 2005-10-11

Publications (2)

Publication Number Publication Date
WO2006058043A2 WO2006058043A2 (fr) 2006-06-01
WO2006058043A3 true WO2006058043A3 (fr) 2009-04-16

Family

ID=36498485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042399 WO2006058043A2 (fr) 2004-11-23 2005-11-23 Vaccins contraceptifs pour chiens et chats a base d'antigenes issus de membrane d'oeuf

Country Status (1)

Country Link
WO (1) WO2006058043A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053339A2 (fr) * 2000-01-20 2001-07-26 University Of Virginia Patent Foundation Proteines de surface specifiques de l'oeuf
WO2002090531A2 (fr) * 2001-05-03 2002-11-14 Akzo Nobel N.V. Peptidylarginine deiminase 6

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053339A2 (fr) * 2000-01-20 2001-07-26 University Of Virginia Patent Foundation Proteines de surface specifiques de l'oeuf
WO2002090531A2 (fr) * 2001-05-03 2002-11-14 Akzo Nobel N.V. Peptidylarginine deiminase 6

Also Published As

Publication number Publication date
WO2006058043A2 (fr) 2006-06-01

Similar Documents

Publication Publication Date Title
WO2000002522A3 (fr) Vaccin du charbon bacteridien
WO2005025614A3 (fr) Ameliorations concernant la vaccination
SG153874A1 (en) Neutralizing epitope-based growth enhancing vaccine
WO2007024947A3 (fr) Vaccins contre la grippe canine
WO2007062656A3 (fr) Vaccin nucléotidique
EP2526966A3 (fr) Vaccins de sous-unité combinés du virus de l'herpès simple et procédés d'utilisation associés
WO2002079243A3 (fr) Proteines gonococciques et acides nucleiques
WO2004062597A3 (fr) Compositions, methodes et trousses renforçant l'immunogenecite d'un vecteur de vaccin bacterien
WO2006081007A3 (fr) Utilisation de flagelline en immunotherapie antitumorale
EA200800837A1 (ru) Иммуностимулирующая одноцепочечная рибонуклеиновая кислота с фосфодиэфирным остовом
WO2005070958A3 (fr) Sous-unites vaccinales de lawsonia intracellularis
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
EP1220925B8 (fr) Antigenes de chlamydia , fragments d'adn correspondants et utilisations
WO2005009378A3 (fr) Polypeptides utilises pour induire une reponse immunitaire vis-a-vis du staphylocoque dore
WO2002024739A3 (fr) Antigene du cancer spas-1
WO2007005627A3 (fr) Essais de detection d'antigenes de la tuberculose et vaccins
WO2006117538A3 (fr) Dosages et leur utilisation
WO2006110915A3 (fr) Formulations de vaccins pour leishmania
WO2007082105A3 (fr) Vaccin contre chlamydia
WO2005026200A3 (fr) Vaccin sous-unite contre lawsonia intracellularis
WO2006058043A3 (fr) Vaccins contraceptifs pour chiens et chats a base d'antigenes issus de membrane d'oeuf
WO2005048918A3 (fr) Vaccin contre l'anthrax
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
ATE374622T1 (de) Genetische impstoffe mit adjuvans

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05852043

Country of ref document: EP

Kind code of ref document: A2